Top India Drugmaker Sun to Buy US Oncology Firm for $355 Million – Bloomberg

1. Top India Drugmaker Sun to Buy US Oncology Firm for $355 Million  Bloomberg
2. Sun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments  CNBCTV18
3. Sun Pharma to acquire US oncology compony for over Rs 3,000 crore  The Times of India
4. Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million or over Rs 3,000 crore  Moneycontrol
5. Indian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million  Forbes

 Top India Drugmaker Sun to Buy US Oncology Firm for $355 Million  BloombergSun Pharma to acquire Checkpoint Therapeutics for $355 million in cash and milestone payments  CNBCTV18Sun Pharma to acquire US oncology compony for over Rs 3,000 crore  The Times of IndiaSun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million or over Rs 3,000 crore  MoneycontrolIndian Billionaire Dilip Shanghvi’s Sun Pharma To Buy U.S. Cancer Drug Maker For $355 Million  Forbes  Top stories – Google News